id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2022-N-0002-0050,FDA,FDA-2022-N-0002,New Animal Drugs; Approval of New Animal Drug Applications; Change of Sponsor,Rule,Final Rule,2023-03-20T04:00:00Z,2023,3,2023-03-20T04:00:00Z,,2023-03-20T13:29:00Z,2023-05465,0,0,09000064857fdf5e
FDA-2022-N-0002-0041,FDA,FDA-2022-N-0002,FOI Summary oA 200-730 approved November 4 2022,Supporting & Related Material,Background Material,2023-03-17T04:00:00Z,2023,3,,,2023-03-17T13:51:32Z,,0,0,09000064857cc6ec
FDA-2022-N-0002-0045,FDA,FDA-2022-N-0002,FOI Summary sA 200-377 approved December 2 2022,Supporting & Related Material,Background Material,2023-03-17T04:00:00Z,2023,3,,,2023-03-17T13:52:09Z,,0,0,09000064857cc6f1
FDA-2022-N-0002-0040,FDA,FDA-2022-N-0002,EAsN 141-450 approved December 23 2022,Supporting & Related Material,Background Material,2023-03-17T04:00:00Z,2023,3,,,2023-03-17T13:51:25Z,,0,0,09000064857cc6eb
FDA-2022-N-0002-0043,FDA,FDA-2022-N-0002,FOI Summary oN 141-566 approved December 8 2022,Supporting & Related Material,Background Material,2023-03-17T04:00:00Z,2023,3,,,2023-03-17T13:51:46Z,,0,0,09000064857cc58a
FDA-2022-N-0002-0048,FDA,FDA-2022-N-0002,FOI Summary sN 141-529 approved December 2 2022,Supporting & Related Material,Background Material,2023-03-17T04:00:00Z,2023,3,,,2023-03-17T13:52:41Z,,0,0,09000064857cc6f4
FDA-2022-N-0002-0049,FDA,FDA-2022-N-0002,FONSI sN 141-450 approved December 2 2022,Supporting & Related Material,Background Material,2023-03-17T04:00:00Z,2023,3,,,2023-03-17T13:52:59Z,,0,0,09000064857cc785
FDA-2022-N-0002-0042,FDA,FDA-2022-N-0002,FOI Summary oN 141-559 approved December 20 2022,Supporting & Related Material,Background Material,2023-03-17T04:00:00Z,2023,3,,,2023-03-17T13:51:39Z,,0,0,09000064857cc589
FDA-2022-N-0002-0044,FDA,FDA-2022-N-0002,FOI Summary oN 141-567 approved November 14 2022,Supporting & Related Material,Background Material,2023-03-17T04:00:00Z,2023,3,,,2023-03-17T13:52:01Z,,0,0,09000064857cc6ef
FDA-2022-N-0002-0047,FDA,FDA-2022-N-0002,FOI Summary sN 141-450 approved December 23 2022,Supporting & Related Material,Background Material,2023-03-17T04:00:00Z,2023,3,,,2023-03-17T13:52:34Z,,0,0,09000064857cc6f3
FDA-2022-N-0002-0046,FDA,FDA-2022-N-0002,FOI Summary sA 200-455 approved December 15 2022,Supporting & Related Material,Background Material,2023-03-17T04:00:00Z,2023,3,,,2023-03-17T13:52:18Z,,0,0,09000064857cc780
FDA-2022-N-0002-0039,FDA,FDA-2022-N-0002,New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Applications; Change of Sponsor; Change of Sponsor Name and Address,Rule,Final Rule,2023-03-10T05:00:00Z,2023,3,2023-03-10T05:00:00Z,,2023-03-10T14:16:10Z,2023-03649,0,0,090000648578b486
FDA-2022-N-0002-0031,FDA,FDA-2022-N-0002,"FOI Summary oN 141-564 approved July 28, 2022",Supporting & Related Material,Background Material,2023-03-09T05:00:00Z,2023,3,,,2023-03-09T13:32:47Z,,0,0,090000648577904e
FDA-2022-N-0002-0021,FDA,FDA-2022-N-0002,"EA sN 141-348 approved July 18, 2022",Supporting & Related Material,Background Material,2023-03-09T05:00:00Z,2023,3,,,2023-03-09T13:30:47Z,,0,0,090000648577897f
FDA-2022-N-0002-0024,FDA,FDA-2022-N-0002,"FOI Summary oA 200-724 approved July 19, 2022",Supporting & Related Material,Background Material,2023-03-09T05:00:00Z,2023,3,,,2023-03-09T13:31:15Z,,0,0,09000064857789d2
FDA-2022-N-0002-0029,FDA,FDA-2022-N-0002,"FOI Summary oN 141-462 approved September 6, 2022",Supporting & Related Material,Background Material,2023-03-09T05:00:00Z,2023,3,,,2023-03-09T13:32:33Z,,0,0,09000064857789d5
FDA-2022-N-0002-0032,FDA,FDA-2022-N-0002,"FOI Summary oN 141-565 approved August 11, 2022",Supporting & Related Material,Background Material,2023-03-09T05:00:00Z,2023,3,,,2023-03-09T13:33:08Z,,0,0,0900006485779051
FDA-2022-N-0002-0034,FDA,FDA-2022-N-0002,"FOI Summary sN 141-348 approved July 18, 2022",Supporting & Related Material,Background Material,2023-03-09T05:00:00Z,2023,3,,,2023-03-09T13:33:43Z,,0,0,09000064857791a2
FDA-2022-N-0002-0038,FDA,FDA-2022-N-0002,"FONSI sN 141-348 approved July 18, 2022",Supporting & Related Material,Background Material,2023-03-09T05:00:00Z,2023,3,,,2023-03-09T13:34:52Z,,0,0,09000064857792f7
FDA-2022-N-0002-0020,FDA,FDA-2022-N-0002,"EA sN 141-043 approved July 18, 2022",Supporting & Related Material,Background Material,2023-03-09T05:00:00Z,2023,3,,,2023-03-09T13:30:40Z,,0,0,090000648577897b
FDA-2022-N-0002-0022,FDA,FDA-2022-N-0002,"FOI Summary oA 200-694 approved September 29, 2022",Supporting & Related Material,Background Material,2023-03-09T05:00:00Z,2023,3,,,2023-03-09T13:30:54Z,,0,0,0900006485778963
FDA-2022-N-0002-0023,FDA,FDA-2022-N-0002,"FOI Summary oA 200-719 approved September 28, 2022",Supporting & Related Material,Background Material,2023-03-09T05:00:00Z,2023,3,,,2023-03-09T13:31:09Z,,0,0,0900006485778984
FDA-2022-N-0002-0025,FDA,FDA-2022-N-0002,"FOI Summary oA 200-725 approved July 19, 2022",Supporting & Related Material,Background Material,2023-03-09T05:00:00Z,2023,3,,,2023-03-09T13:31:28Z,,0,0,0900006485778e8a
FDA-2022-N-0002-0026,FDA,FDA-2022-N-0002,"FOI Summary oA 200-726 approved July 29, 2022",Supporting & Related Material,Background Material,2023-03-09T05:00:00Z,2023,3,,,2023-03-09T13:31:48Z,,0,0,0900006485778e8b
FDA-2022-N-0002-0027,FDA,FDA-2022-N-0002,"FOI Summary oA 200-727 approved July 29, 2022",Supporting & Related Material,Background Material,2023-03-09T05:00:00Z,2023,3,,,2023-03-09T13:32:10Z,,0,0,0900006485778e8c
FDA-2022-N-0002-0030,FDA,FDA-2022-N-0002,"FOI Summary oN 141-553 approved September 9, 2022",Supporting & Related Material,Background Material,2023-03-09T05:00:00Z,2023,3,,,2023-03-09T13:32:40Z,,0,0,0900006485778e92
FDA-2022-N-0002-0033,FDA,FDA-2022-N-0002,"FOI Summary sN 141-043 approved July 18, 2022",Supporting & Related Material,Background Material,2023-03-09T05:00:00Z,2023,3,,,2023-03-09T13:33:22Z,,0,0,090000648577912c
FDA-2022-N-0002-0036,FDA,FDA-2022-N-0002,"FOI Summary sN 141-518 approved August 9, 2022",Supporting & Related Material,Background Material,2023-03-09T05:00:00Z,2023,3,,,2023-03-09T13:34:21Z,,0,0,09000064857791a9
FDA-2022-N-0002-0037,FDA,FDA-2022-N-0002,"FONSI sN 141-043 approved July 18, 2022",Supporting & Related Material,Background Material,2023-03-09T05:00:00Z,2023,3,,,2023-03-09T13:34:41Z,,0,0,09000064857792f6
FDA-2022-N-0002-0028,FDA,FDA-2022-N-0002,"FOI Summary oN 141-429 approved September 6, 2022",Supporting & Related Material,Background Material,2023-03-09T05:00:00Z,2023,3,,,2023-03-09T13:32:18Z,,0,0,09000064857789d4
FDA-2022-N-0002-0035,FDA,FDA-2022-N-0002,"FOI Summary sN 141-459 approved august 9, 2022",Supporting & Related Material,Background Material,2023-03-09T05:00:00Z,2023,3,,,2023-03-09T13:34:08Z,,0,0,09000064857791a3
FDA-2022-N-0002-0017,FDA,FDA-2022-N-0002,New Animal Drugs; Approval of New Animal Drug Applications; Change of Sponsor; Change of Sponsor Address,Rule,Final Rule,2022-12-14T05:00:00Z,2022,12,2022-12-14T05:00:00Z,,2022-12-14T15:03:27Z,2022-24106,0,0,0900006485536264
FDA-2022-N-0002-0018,FDA,FDA-2022-N-0002,"FOI Summary for cN 141-556, approved June 16, 2022",Supporting & Related Material,Background Material,2022-12-14T05:00:00Z,2022,12,,,2022-12-14T17:15:26Z,,0,0,090000648553667b
FDA-2022-N-0002-0019,FDA,FDA-2022-N-0002,"FOI Summary for sN 141-137, approved April 28, 2022",Supporting & Related Material,Background Material,2022-12-14T05:00:00Z,2022,12,,,2022-12-14T17:16:06Z,,0,0,090000648553667c
FDA-2022-N-0002-0004,FDA,FDA-2022-N-0002,FOI Summary oA 200-707 approved January 25 2022,Supporting & Related Material,Background Material,2022-09-29T04:00:00Z,2022,9,,,2022-09-29T20:15:18Z,,0,0,0900006485381e58
FDA-2022-N-0002-0010,FDA,FDA-2022-N-0002,FOI Summary oA 200-716 approved January 28 2022,Supporting & Related Material,Background Material,2022-09-29T04:00:00Z,2022,9,,,2022-09-29T20:16:19Z,,0,0,0900006485381e5e
FDA-2022-N-0002-0008,FDA,FDA-2022-N-0002,FOI Summary oA 200-723 approved March 23 2022,Supporting & Related Material,Background Material,2022-09-29T04:00:00Z,2022,9,,,2022-09-29T20:16:01Z,,0,0,0900006485381e5c
FDA-2022-N-0002-0016,FDA,FDA-2022-N-0002,FOI Summary sN 131-675 approved January 10 2022,Supporting & Related Material,Background Material,2022-09-29T04:00:00Z,2022,9,,,2022-09-29T20:17:36Z,,0,0,0900006485381e75
FDA-2022-N-0002-0003,FDA,FDA-2022-N-0002,FOI Summary oA 200-688 approved March 28 2022,Supporting & Related Material,Background Material,2022-09-29T04:00:00Z,2022,9,,,2022-09-29T20:15:10Z,,0,0,0900006485381696
FDA-2022-N-0002-0005,FDA,FDA-2022-N-0002,FOI Summary oA 200-715 approved February 9 2022,Supporting & Related Material,Background Material,2022-09-29T04:00:00Z,2022,9,,,2022-09-29T20:15:31Z,,0,0,0900006485381e59
FDA-2022-N-0002-0001,FDA,FDA-2022-N-0002,New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Applications; Change of Sponsor; Change of Sponsor Name and Address,Rule,Final Rule,2022-09-29T04:00:00Z,2022,9,2022-09-29T04:00:00Z,,2022-09-29T13:00:29Z,2022-20836,0,0,090000648538095f
FDA-2022-N-0002-0006,FDA,FDA-2022-N-0002,FOI Summary oA 200-721 approved March 28 2022,Supporting & Related Material,Background Material,2022-09-29T04:00:00Z,2022,9,,,2022-09-29T20:15:44Z,,0,0,0900006485381e5a
FDA-2022-N-0002-0007,FDA,FDA-2022-N-0002,FOI Summary oA 200-722 approved March 28 2022,Supporting & Related Material,Background Material,2022-09-29T04:00:00Z,2022,9,,,2022-09-29T20:15:52Z,,0,0,0900006485381e5b
FDA-2022-N-0002-0012,FDA,FDA-2022-N-0002,FOI Summary oA 200-718 approved February 7 2022,Supporting & Related Material,Background Material,2022-09-29T04:00:00Z,2022,9,,,2022-09-29T20:16:46Z,,0,0,0900006485381e60
FDA-2022-N-0002-0011,FDA,FDA-2022-N-0002,FOI Summary oA 200-717 approved February 7 2022,Supporting & Related Material,Background Material,2022-09-29T04:00:00Z,2022,9,,,2022-09-29T20:16:33Z,,0,0,0900006485381e5f
FDA-2022-N-0002-0009,FDA,FDA-2022-N-0002,FOI Summary oN 141-546 approved January 13 2022,Supporting & Related Material,Background Material,2022-09-29T04:00:00Z,2022,9,,,2022-09-29T20:16:11Z,,0,0,0900006485381e5d
FDA-2022-N-0002-0014,FDA,FDA-2022-N-0002,FOI Summary oN 141-547 approved January 20 2022,Supporting & Related Material,Background Material,2022-09-29T04:00:00Z,2022,9,,,2022-09-29T20:17:11Z,,0,0,0900006485381e73
FDA-2022-N-0002-0002,FDA,FDA-2022-N-0002,FOI Summary oA 200-665 approved February 7 2022,Supporting & Related Material,Background Material,2022-09-29T04:00:00Z,2022,9,,,2022-09-29T20:14:56Z,,0,0,0900006485381695
FDA-2022-N-0002-0015,FDA,FDA-2022-N-0002,FOI Summary oN 141-551 approved March 30 2022,Supporting & Related Material,Background Material,2022-09-29T04:00:00Z,2022,9,,,2022-09-29T20:17:23Z,,0,0,0900006485381e74
FDA-2022-N-0002-0013,FDA,FDA-2022-N-0002,FOI Summary oA 200-720 approved March 11 2022,Supporting & Related Material,Background Material,2022-09-29T04:00:00Z,2022,9,,,2022-09-29T20:17:00Z,,0,0,0900006485381e61